Profil
Andrew Allars is currently the Chairman of Azellon Ltd.
and the Managing Partner of Anauel LLP since 2003.
He was previously the Chief Executive Officer of Wyvern Asset Management Ltd.
and a Director at Prelude Ventures Ltd.
from 1990 to 2003.
He was also a Director at KWS BioTest Ltd.
from 2012 to 2019.
Allars holds an MBA from Cranfield University and an undergraduate degree from Southampton Business School.
Postes actifs de Andrew Allars
| Sociétés | Poste | Début |
|---|---|---|
Azellon Ltd.
 Azellon Ltd. Miscellaneous Commercial ServicesCommercial Services Azellon Ltd. develops stem cell therapy for the repair of avascular meniscal tears. The firm's meniscal repair technology combines bone marrow stem cells with a special membrane that helps to deliver the cells into the injured site. The company was founded by Anthony Hollander and Troels Jordansen in 2007 and is headquartered in London, the United Kingdom. | Président | - |
| Anauel LLP | Corporate Officer/Principal | 01/01/2003 |
Anciens postes connus de Andrew Allars
| Sociétés | Poste | Fin |
|---|---|---|
KWS BioTest Ltd.
 KWS BioTest Ltd. Pharmaceuticals: MajorHealth Technology KWS BioTest Ltd. provides preclinical pharmacology and drug development for human diseases. Its capabilities include clinical biomarkers, cell biology, bioanalytical services, in vivo pharmacology, vaccine development. The company was founded by Williams A. Neil and Trevor Langley in 2004 and is headquartered in Bristol, the United Kingdom. | Corporate Officer/Principal | 01/01/2019 |
Prelude Ventures Ltd.
 Prelude Ventures Ltd. Investment ManagersFinance Prelude Ventures Ltd. used to provide investment services for startup companies. Its main targets were advanced materials, communications, drug discovery, medical devices and semiconductor sectors. The company was founded in 1984 and was located in Cambridge, UK. | Corporate Officer/Principal | 01/01/2003 |
Wyvern Asset Management Ltd.
 Wyvern Asset Management Ltd. Investment ManagersFinance Wyvern Asset Management Ltd. (Wyvern Asset Management) is an independent venture capital firm founded in 1999. The firm is headquartered in Bristol, United Kingdom. | Directeur Général | - |
Formation de Andrew Allars
| Cranfield University | Masters Business Admin |
| Southampton Business School | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Prelude Ventures Ltd.
Prelude Ventures Ltd. Investment ManagersFinance Prelude Ventures Ltd. used to provide investment services for startup companies. Its main targets were advanced materials, communications, drug discovery, medical devices and semiconductor sectors. The company was founded in 1984 and was located in Cambridge, UK. | Finance |
Wyvern Asset Management Ltd.
Wyvern Asset Management Ltd. Investment ManagersFinance Wyvern Asset Management Ltd. (Wyvern Asset Management) is an independent venture capital firm founded in 1999. The firm is headquartered in Bristol, United Kingdom. | Finance |
KWS BioTest Ltd.
KWS BioTest Ltd. Pharmaceuticals: MajorHealth Technology KWS BioTest Ltd. provides preclinical pharmacology and drug development for human diseases. Its capabilities include clinical biomarkers, cell biology, bioanalytical services, in vivo pharmacology, vaccine development. The company was founded by Williams A. Neil and Trevor Langley in 2004 and is headquartered in Bristol, the United Kingdom. | Health Technology |
Azellon Ltd.
Azellon Ltd. Miscellaneous Commercial ServicesCommercial Services Azellon Ltd. develops stem cell therapy for the repair of avascular meniscal tears. The firm's meniscal repair technology combines bone marrow stem cells with a special membrane that helps to deliver the cells into the injured site. The company was founded by Anthony Hollander and Troels Jordansen in 2007 and is headquartered in London, the United Kingdom. | Commercial Services |
| Anauel LLP |
